Reaction
Lymphocele reporting signals
As of the last recalculation, Lymphocele appears in 660 FAERS reports alongside 26 co-occurring drug terms. The strongest observed disproportionality signal is BASILIXIMAB (PRR 206.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Basiliximab | 69 | 206.5 | 207.7 |
| Valganciclovir Hydrochloride Powder, | 36 | 98.4 | 98.7 |
| Valganciclovir | 54 | 98.3 | 98.6 |
| Valganciclovir Hydrochloride | 54 | 98.3 | 98.6 |
| Mycophenolic Acid | 82 | 92.1 | 92.4 |
| Sirolimus | 36 | 89.1 | 89.3 |
| Anti-Thymocyte Globulin (Rabbit) | 22 | 88.9 | 89.2 |
| Everolimus Tablets | 38 | 75.8 | 75.9 |
| Mycophenolate Mofetil | 213 | 72.5 | 72.7 |
| Mycophenolate Mofetil Hydrochloride | 213 | 72.4 | 72.5 |
| Tacrolimus | 207 | 60.3 | 60.3 |
| Tacrolimus Ointment 0.1% | 165 | 55.4 | 55.5 |
| Tacrolimus Extended-Release Capsules | 165 | 55.2 | 55.3 |
| Cyclosporine | 140 | 50.1 | 50.2 |
| Cortisone Acetate | 18 | 47.2 | 47.3 |
| Mycophenilic Acid | 25 | 39.5 | 39.6 |
| Ganciclovir Sodium | 9 | 27.2 | 27.2 |
| Acetylcysteine | 8 | 27.1 | 27.1 |
| Everolimus | 40 | 26.3 | 26.3 |
| Amphotericin B | 10 | 25.5 | 25.6 |
| Magnesium Sulfate In Water For | 10 | 25.1 | 25.1 |
| Ganciclovir | 8 | 24.9 | 25.0 |
| Magnesium Sulfate Heptahydrate | 10 | 24.6 | 24.6 |
| Magnesium Sulfate | 10 | 24.5 | 24.5 |
| Darbepoetin Alfa | 23 | 13.9 | 13.9 |
| Rocuronium Bromide | 5 | 13.5 | 13.5 |